Vireo Growth Inc.
VREOF · OTCMCIK 1771706fmd_1KB15DRKCT6VKRKQ9NN33T2613Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2020 to Sep 30, 2026, 27 periods
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Total revenues | 49 | 54 | 75 | 88 | 99 | 269 |
| Cost of revenue | 31 | 32 | 39 | – | – | – |
| Gross profit | 17 | 20 | 31 | 44 | 51 | 127 |
| Selling, general and administrative | 26 | 34 | 34 | 28 | 28 | 81 |
| Compensation and benefits | 13 | 16 | 17 | 15 | 14 | 47 |
| Total operating expenses | 40 | 40 | 38 | 34 | 37 | 128 |
| Operating income | (23) | (20) | (7) | 11 | 14 | (1) |
| Interest expense | 5 | 11 | 23 | 31 | 31 | – |
| Other non-operating income (expense) | 9 | (9) | (30) | (28) | (30) | (39) |
| Income before taxes | (14) | (30) | (37) | (18) | (17) | (40) |
| Income tax expense | 9 | 4 | 6 | 8 | 11 | 28 |
| Net income from continuing operations | (23) | (34) | (42) | (26) | (28) | (68) |
| Net income | (23) | (34) | (42) | (26) | (28) | (68) |